Cortexyme, Inc.
CRTX
Transaktioner
184
Köp
63
Sälj
121
Nettoinsynsflöde
-19.5 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
184 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2022-06-06 | McDowell Caryn Gordon | Chief Legal & Adm. Officer | Sell | 7 k | 2,86 | 19 k USD |
| 2022-06-06 | McDowell Caryn Gordon | Chief Legal & Adm. Officer | Sell | 11 k | 2,86 | 31 k USD |
| 2022-06-06 | Holsinger Leslie | EVP, Preclinical Development | Sell | 11 k | 2,86 | 31 k USD |
| 2022-06-06 | Monohon Ted | Chief Accounting Officer & VP | Sell | 2 k | 3,12 | 5 k USD |
| 2022-06-06 | Holsinger Leslie | EVP, Preclinical Development | Sell | 11 k | 2,86 | 31 k USD |
| 2022-06-06 | McDowell Caryn Gordon | Chief Legal & Adm. Officer | Sell | 7 k | 2,86 | 19 k USD |
| 2022-06-06 | McDowell Caryn Gordon | Chief Legal & Adm. Officer | Sell | 11 k | 2,86 | 31 k USD |
| 2022-06-06 | Monohon Ted | Chief Accounting Officer & VP | Sell | 2 k | 3,12 | 5 k USD |
| 2022-05-19 | Hannah Brendan | Chief Business Officer | Buy | 16 k | – | – |
| 2022-05-19 | Lamond David | Director | Buy | 200 k | – | – |
| 2022-05-19 | Low Philip S | Director | Buy | 455 k | – | – |
| 2022-05-19 | Low Philip S | Director | Buy | 64 k | – | – |
| 2022-05-19 | Smith Karen L. | Chief Medical Officer | Buy | 24 k | – | – |
| 2022-05-19 | Thye Dirk | Chief Executive Officer | Buy | 65 k | – | – |
| 2022-05-19 | Hannah Brendan | Chief Business Officer | Buy | 16 k | – | – |
| 2022-05-19 | Lamond David | Director | Buy | 200 k | – | – |
| 2022-05-19 | Low Philip S | Director | Buy | 455 k | – | – |
| 2022-05-19 | Low Philip S | Director | Buy | 64 k | – | – |
| 2022-05-19 | Smith Karen L. | Chief Medical Officer | Buy | 24 k | – | – |
| 2022-05-19 | Thye Dirk | Chief Executive Officer | Buy | 65 k | – | – |
| 2022-03-03 | Detke Michael J. | Chief Medical Officer | Buy | 140 k | 0,00 | 0 USD |
| 2022-03-03 | Holsinger Leslie | EVP, Preclinical Development | Buy | 156 k | 0,00 | 0 USD |
| 2022-03-03 | LOWE CHRISTOPHER P. | Interim CEO, COO & CFO | Buy | 175 k | 0,00 | 0 USD |
| 2022-03-03 | McDowell Caryn Gordon | Chief Legal & Adm. Officer | Buy | 140 k | 0,00 | 0 USD |
| 2022-03-03 | Monohon Ted | Chief Accounting Officer & VP | Buy | 34 k | 0,00 | 0 USD |
| 2022-03-03 | Detke Michael J. | Chief Medical Officer | Buy | 140 k | 0,00 | 0 USD |
| 2022-03-03 | Holsinger Leslie | EVP, Preclinical Development | Buy | 156 k | 0,00 | 0 USD |
| 2022-03-03 | LOWE CHRISTOPHER P. | Interim CEO, COO & CFO | Buy | 175 k | 0,00 | 0 USD |
| 2022-03-03 | McDowell Caryn Gordon | Chief Legal & Adm. Officer | Buy | 140 k | 0,00 | 0 USD |
| 2022-03-03 | Monohon Ted | Chief Accounting Officer & VP | Buy | 34 k | 0,00 | 0 USD |
| 2021-11-18 | Lynch Casey | Chief Executive Officer | Buy | 60 k | 0,46 | 28 k USD |
| 2021-11-18 | Lynch Casey | Chief Executive Officer | Buy | 60 k | 0,46 | 28 k USD |
| 2021-11-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Buy | 30 k | 2,23 | 67 k USD |
| 2021-11-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Buy | 30 k | 2,23 | 67 k USD |
| 2021-11-12 | Dominy Stephen S. | Chief Scientific Officer | Buy | 763 | 14,40 | 11 k USD |
| 2021-11-12 | Dominy Stephen S. | Chief Scientific Officer | Buy | 763 | 14,40 | 11 k USD |
| 2021-10-08 | McLoughlin Margaret | Director | Buy | 1 k | 17,00 | 17 k USD |
| 2021-10-08 | McLoughlin Margaret | Director | Sell | 1 k | 88,93 | 89 k USD |
| 2021-10-08 | McLoughlin Margaret | Director | Buy | 1 k | 17,00 | 17 k USD |
| 2021-10-08 | McLoughlin Margaret | Director | Sell | 1 k | 88,93 | 89 k USD |
| 2021-10-05 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Buy | 5 k | 54,85 | 272 k USD |
| 2021-10-05 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 5 k | 98,50 | 489 k USD |
| 2021-10-05 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Buy | 5 k | 54,85 | 272 k USD |
| 2021-10-05 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 5 k | 98,50 | 489 k USD |
| 2021-08-17 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Buy | 30 k | 2,23 | 67 k USD |
| 2021-08-17 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Buy | 30 k | 2,23 | 67 k USD |
| 2021-08-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Buy | 22 k | 2,23 | 49 k USD |
| 2021-08-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 9 k | 94,23 | 863 k USD |
| 2021-08-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 7 k | 95,02 | 697 k USD |
| 2021-08-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 2 k | 96,32 | 224 k USD |
| 2021-08-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 1 k | 97,28 | 107 k USD |
| 2021-08-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 2 k | 98,90 | 205 k USD |
| 2021-08-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Buy | 22 k | 2,23 | 49 k USD |
| 2021-08-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 9 k | 94,23 | 863 k USD |
| 2021-08-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 7 k | 95,02 | 697 k USD |
| 2021-08-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 2 k | 96,32 | 224 k USD |
| 2021-08-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 1 k | 97,28 | 107 k USD |
| 2021-08-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 2 k | 98,90 | 205 k USD |
| 2021-08-16 | McLoughlin Margaret | Director | Buy | 6 k | 17,00 | 102 k USD |
| 2021-08-16 | McLoughlin Margaret | Director | Sell | 3 k | 94,55 | 289 k USD |
| 2021-08-16 | McLoughlin Margaret | Director | Sell | 1 k | 95,57 | 100 k USD |
| 2021-08-16 | McLoughlin Margaret | Director | Sell | 1 k | 96,51 | 138 k USD |
| 2021-08-16 | McLoughlin Margaret | Director | Sell | 423 | 97,55 | 41 k USD |
| 2021-08-16 | McLoughlin Margaret | Director | Sell | 48 | 98,90 | 5 k USD |
| 2021-08-10 | Detke Michael J. | Chief Medical Officer | Buy | 10 k | 2,23 | 22 k USD |
| 2021-08-10 | Detke Michael J. | Chief Medical Officer | Sell | 10 k | 100,00 | 1.0 mn USD |
| 2021-08-10 | Detke Michael J. | Chief Medical Officer | Buy | 10 k | 2,23 | 22 k USD |
| 2021-08-10 | Detke Michael J. | Chief Medical Officer | Sell | 10 k | 100,00 | 1.0 mn USD |
| 2021-07-07 | Detke Michael J. | Chief Medical Officer | Sell | 7 k | 56,27 | 391 k USD |
| 2021-07-07 | Detke Michael J. | Chief Medical Officer | Buy | 17 k | 2,23 | 39 k USD |
| 2021-07-07 | Detke Michael J. | Chief Medical Officer | Sell | 4 k | 53,24 | 209 k USD |
| 2021-07-07 | Detke Michael J. | Chief Medical Officer | Sell | 2 k | 54,37 | 90 k USD |
| 2021-07-07 | Detke Michael J. | Chief Medical Officer | Sell | 4 k | 55,38 | 241 k USD |
| 2021-07-07 | Detke Michael J. | Chief Medical Officer | Sell | 523 | 56,99 | 30 k USD |
| 2021-07-07 | Detke Michael J. | Chief Medical Officer | Buy | 17 k | 2,23 | 39 k USD |
| 2021-07-07 | Detke Michael J. | Chief Medical Officer | Sell | 4 k | 53,24 | 209 k USD |
| 2021-07-07 | Detke Michael J. | Chief Medical Officer | Sell | 2 k | 54,37 | 90 k USD |
| 2021-07-07 | Detke Michael J. | Chief Medical Officer | Sell | 4 k | 55,38 | 241 k USD |
| 2021-07-07 | Detke Michael J. | Chief Medical Officer | Sell | 7 k | 56,27 | 391 k USD |
| 2021-07-07 | Detke Michael J. | Chief Medical Officer | Sell | 523 | 56,99 | 30 k USD |
| 2021-07-06 | Detke Michael J. | Chief Medical Officer | Buy | 13 k | 2,23 | 28 k USD |
| 2021-07-06 | Detke Michael J. | Chief Medical Officer | Sell | 32 k | 53,43 | 1.7 mn USD |
| 2021-07-06 | Detke Michael J. | Chief Medical Officer | Sell | 8 k | 53,91 | 445 k USD |
| 2021-07-06 | Detke Michael J. | Chief Medical Officer | Sell | 288 | 55,01 | 16 k USD |
| 2021-07-06 | Detke Michael J. | Chief Medical Officer | Buy | 13 k | 2,23 | 28 k USD |
| 2021-07-06 | Detke Michael J. | Chief Medical Officer | Sell | 32 k | 53,43 | 1.7 mn USD |
| 2021-07-06 | Detke Michael J. | Chief Medical Officer | Sell | 8 k | 53,91 | 445 k USD |
| 2021-07-06 | Detke Michael J. | Chief Medical Officer | Sell | 288 | 55,01 | 16 k USD |
| 2021-06-30 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Buy | 30 k | 2,23 | 67 k USD |
| 2021-06-30 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Buy | 30 k | 2,23 | 67 k USD |
| 2021-06-28 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Buy | 20 k | 2,23 | 45 k USD |
| 2021-06-28 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 8 k | 53,39 | 412 k USD |
| 2021-06-28 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 7 k | 54,13 | 383 k USD |
| 2021-06-28 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 4 k | 55,11 | 229 k USD |
| 2021-06-28 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 1 k | 56,16 | 59 k USD |
| 2021-06-28 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Buy | 20 k | 2,23 | 45 k USD |
| 2021-06-28 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 8 k | 53,39 | 412 k USD |
| 2021-06-28 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 7 k | 54,13 | 383 k USD |
| 2021-06-28 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 4 k | 55,11 | 229 k USD |
| 2021-06-28 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Sell | 1 k | 56,16 | 59 k USD |
| 2021-06-28 | McLoughlin Margaret | Director | Sell | 200 | 55,01 | 11 k USD |
| 2021-06-28 | McLoughlin Margaret | Director | Sell | 250 | 55,03 | 14 k USD |
| 2021-06-28 | McLoughlin Margaret | Director | Sell | 100 | 55,73 | 6 k USD |
| 2021-06-28 | McLoughlin Margaret | Director | Sell | 200 | 55,01 | 11 k USD |
| 2021-06-28 | McLoughlin Margaret | Director | Sell | 250 | 55,03 | 14 k USD |
| 2021-06-28 | McLoughlin Margaret | Director | Sell | 100 | 55,73 | 6 k USD |
| 2021-05-10 | Lynch Casey | Chief Executive Officer | Sell | 14 k | 33,75 | 458 k USD |
| 2021-05-10 | Lynch Casey | Chief Executive Officer | Sell | 10 k | 34,89 | 346 k USD |
| 2021-05-10 | Lynch Casey | Chief Executive Officer | Sell | 6 k | 35,81 | 226 k USD |
| 2021-05-10 | Lynch Casey | Chief Executive Officer | Sell | 183 | 36,73 | 7 k USD |
| 2021-05-10 | Lynch Casey | Chief Executive Officer | Sell | 14 k | 33,75 | 458 k USD |
| 2021-05-10 | Lynch Casey | Chief Executive Officer | Sell | 10 k | 34,89 | 346 k USD |
| 2021-05-10 | Lynch Casey | Chief Executive Officer | Sell | 6 k | 35,81 | 226 k USD |
| 2021-05-10 | Lynch Casey | Chief Executive Officer | Sell | 183 | 36,73 | 7 k USD |
| 2021-03-24 | Lamond David | Director | Buy | 50 k | 33,77 | 1.7 mn USD |
| 2021-03-24 | Lamond David | Director | Buy | 50 k | 33,77 | 1.7 mn USD |
| 2021-03-22 | Lynch Casey | Chief Executive Officer | Sell | 11 k | 35,10 | 394 k USD |
| 2021-03-22 | Lynch Casey | Chief Executive Officer | Sell | 18 k | 35,85 | 648 k USD |
| 2021-03-22 | Lynch Casey | Chief Executive Officer | Sell | 300 | 36,58 | 11 k USD |
| 2021-03-22 | Lynch Casey | Chief Executive Officer | Sell | 400 | 36,60 | 15 k USD |
| 2021-03-22 | Lynch Casey | Chief Executive Officer | Sell | 11 k | 35,10 | 394 k USD |
| 2021-03-22 | Lynch Casey | Chief Executive Officer | Sell | 18 k | 35,85 | 648 k USD |
| 2021-03-22 | Lynch Casey | Chief Executive Officer | Sell | 300 | 36,58 | 11 k USD |
| 2021-03-22 | Lynch Casey | Chief Executive Officer | Sell | 400 | 36,60 | 15 k USD |
| 2021-03-04 | Lamond David | Director | Buy | 1.5 mn | 0,00 | 0 USD |
| 2021-03-04 | Lamond David | Director | Buy | 1.5 mn | 0,00 | 0 USD |
| 2021-03-04 | Lamond David | Director | Buy | 17 k | 34,28 | 570 k USD |
| 2021-03-04 | Lamond David | Director | Buy | 13 k | 35,00 | 466 k USD |
| 2021-03-04 | Lamond David | Director | Buy | 16 k | 36,34 | 580 k USD |
| 2021-03-04 | Lamond David | Director | Buy | 4 k | 36,86 | 151 k USD |
| 2021-03-04 | Lamond David | Director | Buy | 17 k | 34,28 | 570 k USD |
| 2021-03-04 | Lamond David | Director | Buy | 13 k | 35,00 | 466 k USD |
| 2021-03-04 | Lamond David | Director | Buy | 16 k | 36,34 | 580 k USD |
| 2021-03-04 | Lamond David | Director | Buy | 4 k | 36,86 | 151 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 400 | 37,39 | 15 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 2 k | 38,64 | 62 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 856 | 39,82 | 34 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 2 k | 40,84 | 82 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 3 k | 41,91 | 130 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 2 k | 43,10 | 65 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 2 k | 44,22 | 84 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 8 k | 45,00 | 361 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 600 | 45,73 | 27 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 400 | 37,39 | 15 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 2 k | 38,64 | 62 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 856 | 39,82 | 34 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 2 k | 40,84 | 82 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 3 k | 41,91 | 130 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 2 k | 43,10 | 65 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 2 k | 44,22 | 84 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 8 k | 45,00 | 361 k USD |
| 2021-02-03 | Lynch Casey | Chief Executive Officer | Sell | 600 | 45,73 | 27 k USD |
| 2021-02-02 | Lynch Casey | Chief Executive Officer | Sell | 15 k | 36,02 | 538 k USD |
| 2021-02-02 | Lynch Casey | Chief Executive Officer | Sell | 5 k | 36,75 | 186 k USD |
| 2021-02-02 | Lynch Casey | Chief Executive Officer | Sell | 15 k | 36,02 | 538 k USD |
| 2021-02-02 | Lynch Casey | Chief Executive Officer | Sell | 5 k | 36,75 | 186 k USD |
| 2021-02-01 | Lynch Casey | Chief Executive Officer | Sell | 5 k | 34,60 | 162 k USD |
| 2021-02-01 | Lynch Casey | Chief Executive Officer | Sell | 3 k | 35,59 | 110 k USD |
| 2021-02-01 | Lynch Casey | Chief Executive Officer | Sell | 7 k | 36,56 | 273 k USD |
| 2021-02-01 | Lynch Casey | Chief Executive Officer | Sell | 4 k | 37,68 | 161 k USD |
| 2021-02-01 | Lynch Casey | Chief Executive Officer | Sell | 100 | 38,28 | 4 k USD |
| 2021-02-01 | Lynch Casey | Chief Executive Officer | Sell | 371 | 39,23 | 15 k USD |
| 2021-02-01 | Lynch Casey | Chief Executive Officer | Sell | 5 k | 34,60 | 162 k USD |
| 2021-02-01 | Lynch Casey | Chief Executive Officer | Sell | 3 k | 35,59 | 110 k USD |
| 2021-02-01 | Lynch Casey | Chief Executive Officer | Sell | 7 k | 36,56 | 273 k USD |
| 2021-02-01 | Lynch Casey | Chief Executive Officer | Sell | 4 k | 37,68 | 161 k USD |
| 2021-02-01 | Lynch Casey | Chief Executive Officer | Sell | 100 | 38,28 | 4 k USD |
| 2021-02-01 | Lynch Casey | Chief Executive Officer | Sell | 371 | 39,23 | 15 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Buy | 40 k | 0,27 | 11 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Sell | 2 k | 28,80 | 49 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Sell | 14 k | 30,15 | 430 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Sell | 13 k | 30,91 | 408 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Sell | 10 k | 31,79 | 303 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Sell | 400 | 32,59 | 13 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Sell | 900 | 32,59 | 29 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Buy | 40 k | 0,27 | 11 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Sell | 2 k | 28,80 | 49 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Sell | 14 k | 30,15 | 430 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Sell | 13 k | 30,91 | 408 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Sell | 10 k | 31,79 | 303 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Sell | 400 | 32,59 | 13 k USD |
| 2020-12-14 | Holsinger Leslie | Executive Vice President | Sell | 900 | 32,59 | 29 k USD |
| 2020-12-10 | Holsinger Leslie | Executive Vice President | Buy | 4 k | 0,27 | 945 USD |
| 2020-12-10 | Holsinger Leslie | Executive Vice President | Buy | 4 k | 0,27 | 945 USD |

